Publication
Epidermal Growth Factor Promotes Protein Degradation of Epithelial Protein Lost in Neoplasm (EPLIN), a Putative Metastasis Suppressor, during Epithelial-mesenchymal Transition
Downloadable Content
- Persistent URL
- Last modified
- 02/20/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2013-01-18
- Publisher
- American Society for Biochemistry and Molecular Biology
- Publication Version
- Copyright Statement
- © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.
- Final Published Version (URL)
- Title of Journal or Parent Work
- Volume
- 288
- Issue
- 3
- Start Page
- 1469
- End Page
- 1479
- Grant/Funding Information
- This work was also supported by American Cancer Society Grant RSG-10-140-01 (to D. W.).
- This work was supported, in whole or in part, by NCI, National Institutes of Health Grants 1R21CA164612-01A1 (to D. W), 1R43CA141870 (to Y. A. W), P01 CA098912 and R01 CA122602 (to L. W. K. C), and Georgia Cancer Coalition Distinguished Scholar Grant (to O. K).
- Abstract
- Background: The mechanism of EGF signaling in the regulation of prostate cancer (PCa) metastasis remains unclear. Results: EGF promotes epithelial-mesenchymal transition (EMT) and induces degradation of epithelial protein lost in neoplasm (EPLIN), a putative suppressor of PCa metastasis. Conclusion: EGF activates ERK1/2-dependent phosphorylation, ubiquitination, and protein turnover of EPLIN. Significance: This study suggested that blockade of EGF signaling could retard EMT and inhibit invasiveness of PCa cells.
- Author Notes
- Keywords
- Research Categories
- Health Sciences, Oncology
- Chemistry, Biochemistry
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - scd5g.pdf | Primary Content | 2025-02-06 | Public | Download |